Journal article
RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy
HA Azim, FA Peccatori, S Brohée, D Branstetter, S Loi, G Viale, M Piccart, WC Dougall, G Pruneri, C Sotiriou
Breast Cancer Research | BMC | Published : 2015
Open access
Abstract
Introduction: RANKL is important in mammary gland development during pregnancy and mediates the initiation and progression of progesterone-induced breast cancer. No clinical data are available on the effect of pregnancy on RANK/RANKL expression in young breast cancer patients. Methods: We used our previously published dataset of 65 pregnant and 130 matched young breast cancer patients with full clinical, pathological, and survival information. 85% of patients had available transcriptomic data as well. RANK/RANKL expression by immunohistochemistry using H-score on the primary tumor and adjacent normal tissue was performed. We examined the difference in expression of RANK/RANKL between pregnan..
View full abstractGrants
Funding Acknowledgements
Amgen performed RANK and RANKL testing by immunohistochemistry and funded the transport of tissue samples from IEO to their laboratories. No other funding was provided. Amgen provided input in the interpretation of the data, and review of the manuscript.